Welcome to the Website for the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA).  The NARSA program is funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and is designed to support and facilitate critical research efforts among clinical and basic scientists from the academic, industrial, and public health sectors regarding staphylococcal infections and disease. 

The NARSA program has established an infrastructure that supports cross fertilization of biological, medical, and epidemiological research directed towards understanding antimicrobial resistance and other medically relevant genetic and physiological characteristics among staphylococci.

This infrastructure includes:

·         A continuously expanding, centralized Repository of strains exhibiting reduced susceptibility to vancomycin and other characteristics of research and clinical importance and interest.

·         A database of microbiologic and clinical information that accompanies the Repository of strains.

·         A Website that provides Registered Users with:

1)      access to the NARSA Repository database.

2)      ability to peruse the isolate inventory catalog and order available isolates.

3)      links to other key sources of information regarding staphylococcal research.

4)      a forum for investigators to share and relate their findings and knowledge about recent advances in staphylococcal research.

5)      access to contact information and research interests of other Network participants.

In order to gain access to the isolates available in NARSA's Repository, to view the data collected and maintained for these isolates, and to interact with other Network participants, you must Register with the program.   For additional information or questions concerning NARSA, please see the Program Synopsis or  Contact Us.

NARSA is managed by Eurofins Medinet